In contrast, immunohistochemical analysis of patients with long survival showed low positivity for both CD68 and IL-1β, suggesting that a pro-inflammatory TME correlates with a poor prognosis in early NSCLC. Here, CD68 is linked to non-small cell lung carcinoma.